- Home
- SNWV vs DSM Comparison
SNWV vs DSM Comparison
Compare SNWV & DSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNWV
- DSM
- Stock Information
- Founded
- SNWV 2004
- DSM 1989
- Country
- SNWV United States
- DSM United States
- Employees
- SNWV N/A
- DSM N/A
- Industry
- SNWV
- DSM Investment Managers
- Sector
- SNWV
- DSM Finance
- Exchange
- SNWV NYSE
- DSM Nasdaq
- Market Cap
- SNWV 234.2M
- DSM 270.9M
- IPO Year
- SNWV N/A
- DSM N/A
- Fundamental
- Price
- SNWV $26.20
- DSM $5.55
- Analyst Decision
- SNWV
- DSM
- Analyst Count
- SNWV 0
- DSM 0
- Target Price
- SNWV N/A
- DSM N/A
- AVG Volume (30 Days)
- SNWV 46.1K
- DSM 161.7K
- Earning Date
- SNWV 05-08-2025
- DSM 01-01-0001
- Dividend Yield
- SNWV N/A
- DSM 3.97%
- EPS Growth
- SNWV N/A
- DSM N/A
- EPS
- SNWV N/A
- DSM N/A
- Revenue
- SNWV $36,190,000.00
- DSM N/A
- Revenue This Year
- SNWV N/A
- DSM N/A
- Revenue Next Year
- SNWV N/A
- DSM N/A
- P/E Ratio
- SNWV N/A
- DSM N/A
- Revenue Growth
- SNWV 61.50
- DSM N/A
- 52 Week Low
- SNWV $5.18
- DSM $4.69
- 52 Week High
- SNWV $39.50
- DSM $6.05
- Technical
- Relative Strength Index (RSI)
- SNWV N/A
- DSM 41.17
- Support Level
- SNWV N/A
- DSM $5.55
- Resistance Level
- SNWV N/A
- DSM $5.75
- Average True Range (ATR)
- SNWV 0.00
- DSM 0.06
- MACD
- SNWV 0.00
- DSM -0.02
- Stochastic Oscillator
- SNWV 0.00
- DSM 4.00
About SNWV SANUWAVE HEALTH INC
SANUWAVE Health Inc is an ultrasound and shock wave technology company using patented systems of noninvasive, high-energy, acoustic shock waves or low-intensity and non-contact ultrasound for regenerative medicine and other applications. The company's focus is regenerative medicine utilizing noninvasive, acoustic shock waves or ultrasound to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's two primary systems are UltraMIST and PACE. UltraMIST and PACE are the only two Food and Drug Administration (FDA) approved directed energy systems for wound healing.
About DSM BNY Mellon Strategic Municipal Bond Fund Inc.
BNY Mellon Strategic Municipal Bond Fund, Inc. is a diversified closed-end management investment company. Its investment objective is to seek to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital.